Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for MNOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2003. Start Trial.
Date Value
December 31, 2025 30.81M
December 31, 2024 40.36M
December 31, 2023 51.00M
December 31, 2022 58.49M
December 31, 2021 71.43M
December 31, 2020 60.04M
December 31, 2019 63.79M
December 31, 2018 62.31M
December 31, 2017 27.99M
December 31, 2016 24.12M
December 31, 2015 22.08M
December 31, 2014 11.67M
Date Value
December 31, 2013 6.700M
December 31, 2012 4.010M
December 31, 2011 15.09M
December 31, 2010 57.56M
December 31, 2009 46.05M
December 31, 2008 19.30M
December 31, 2007 70.64M
December 31, 2006 104.05M
December 31, 2005 138.70M
December 31, 2004 50.80M
December 31, 2003 5.491M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 215.46M
Viking Therapeutics, Inc. 705.74M
IDEAYA Biosciences, Inc. 639.39M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B